BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12716857)

  • 1. Metformin and insulin in type 1 diabetes: the first step.
    Meyer L; Guerci B
    Diabetes Care; 2003 May; 26(5):1655-6. PubMed ID: 12716857
    [No Abstract]   [Full Text] [Related]  

  • 2. The insulin-sparing effect of metformin in insulin-treated diabetic patients.
    Golay A; Guillet-Dauphiné N; Fendel A; Juge C; Assal JP
    Diabetes Metab Rev; 1995 Sep; 11 Suppl 1():S63-7. PubMed ID: 8529487
    [No Abstract]   [Full Text] [Related]  

  • 3. Metformin use as an adjunct to insulin treatment.
    Gunton JE; Twigg SM
    Med J Aust; 2003 Jun; 178(11):591-2. PubMed ID: 12765513
    [No Abstract]   [Full Text] [Related]  

  • 4. What role for metformin in type 1 diabetes?
    Drug Ther Bull; 2018 Jul; 56(7):78-80. PubMed ID: 30008442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and insulin: is there a role for combination therapy?
    Daniel JR; Hagmeyer KO
    Ann Pharmacother; 1997 Apr; 31(4):474-80. PubMed ID: 9101010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control. Reply to Schatz H [letter].
    Vella S; Buetow L; Royle P; Livingstone S; Petrie JR
    Diabetologia; 2011 Jan; 54(1):203-4. PubMed ID: 21046359
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes.
    Bacha F; Klinepeter Bartz S
    Pediatr Diabetes; 2016 Dec; 17(8):545-558. PubMed ID: 26592507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: an analysis based on a large diabetes registry in Germany and Austria.
    Konrad K; Datz N; Engelsberger I; Grulich-Henn J; Hoertenhuber T; Knauth B; Meissner T; Wiegand S; Woelfle J; Holl RW;
    Pediatr Diabetes; 2015 Nov; 16(7):529-37. PubMed ID: 25131985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin in type 1 diabetes: is this a good or bad idea?
    Faichney JD; Tate PW
    Diabetes Care; 2003 May; 26(5):1655. PubMed ID: 12716858
    [No Abstract]   [Full Text] [Related]  

  • 10. [Insulin sparing and metabolic control with metformin-insulin combination].
    Isnard F
    Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM; Raskin P
    Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin as adjuvant to insulin therapy in type 2 diabetic patients.
    Vanamo R
    Diabetes Care; 1999 Mar; 22(3):528. PubMed ID: 10097944
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutting the Gordian knot. Addition of metformin to insulin therapy in a patient with uncontrolled diabetes and schizophrenia.
    McDonnell ME; Ruderman NB
    Diabetes Care; 1999 Nov; 22(11):1912-3. PubMed ID: 10546035
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin monotherapy vs. combination therapy.
    Ebell MH
    Am Fam Physician; 2005 Mar; 71(5):899. PubMed ID: 15768618
    [No Abstract]   [Full Text] [Related]  

  • 15. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients: response to Poulsen et al.
    Mikhail N
    Diabetes Care; 2004 Jul; 27(7):1846-7; author reply 1847-8. PubMed ID: 15220287
    [No Abstract]   [Full Text] [Related]  

  • 16. [Remission of insulin-dependent diabetes (IDD). Insulin requirements of non-insulin-dependent diabetes (NIDD). The role of oral antidiabetics and the value of metformin].
    Isnard F; Ibagnez A; Andre P
    Journ Annu Diabetol Hotel Dieu; 1986; ():303-12. PubMed ID: 3613375
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between adjunctive metformin therapy in young type 1 diabetes patients with excess body fat and reduction of carotid intima-media thickness.
    Burchardt P; Zawada A; Kaczmarek J; Marcinkaniec J; Wysocki H; Wierusz-Wysocka B; Grzymisławski M; Rzeźniczak J; Zozulińska-Ziółkiewicz D; Naskręt D
    Pol Arch Med Wewn; 2016 Aug; 126(7-8):514-20. PubMed ID: 27578220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin in type 1 diabetes mellitus? Revisiting treatment dogmas in diabetes.
    Klupa T
    Pol Arch Med Wewn; 2016 Aug; 126(7-8):461-2. PubMed ID: 27578217
    [No Abstract]   [Full Text] [Related]  

  • 19. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients: response to Rosenstock et al.
    Hamid Z; Simmons DL
    Diabetes Care; 2006 Oct; 29(10):2331; author reply 2332. PubMed ID: 17003324
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control.
    Schatz H
    Diabetologia; 2010 Oct; 53(10):2264-5. PubMed ID: 20617302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.